- 201. Ameloblastic Carcinoma-Primary Type
- (UMLS (NCI) C1333260) De novo Ameloblastic Carcinoma;
Primary Ameloblastic Carcinoma;
=Neoplastic Process ;
| - 251. Amifostine/Busulfan/Melphalan/Thiotepa
- (UMLS (NCI) C0677970) =Therapeutic or Preventive Procedure
|
- 202. Ameloblastic Fibrodentinoma
- (UMLS (NCI) C0457520) =Neoplastic Process
| - 252. Amifostine/Carboplatin
- (UMLS (NCI) C0280482) =Therapeutic or Preventive Procedure ;
|
- 203. Ameloblastic Fibroma
- (UMLS (NCI) C0334572) =Neoplastic Process
| - 253. Amifostine/Carboplatin/Cisplatin
- (UMLS (NCI) C0280846) =Therapeutic or Preventive Procedure
|
- 204. Ameloblastic Fibroodontoma
- (UMLS (NCI) C0205865) =Neoplastic Process ;
| - 254. Amifostine/Carboplatin/Cyclophosphamide
- (UMLS (NCI) C0677805) =Therapeutic or Preventive Procedure
|
- 205. Ameloblastic Fibrosarcoma
- [A locally aggressive malignant neoplasm arising from odontogenic tissue. It occurs in the mandible and less often in the maxilla. It is characterized by the presence of a malignant connective tissue component and a benign epithelial component. The frequency of distal metastases is low. ( NCI )] (UMLS (NCI) C0334573) =Neoplastic Process
| - 255. Amifostine/Carboplatin/Cyclophosphamide/Thiotepa
- (UMLS (NCI) C0796504) CBDCA/CTX/TSPA/WR-2721;
=Therapeutic or Preventive Procedure ;
|
- 206. ameloblastoma
- [The most common odontogenic tumor, arising from the epithelial component of the embryonic tooth and usually affecting the molar-ramus region of the mandible or maxilla. Although most ameloblastomas are morphologically and clinically benign, they may cause extensive local destruction, recur, or metastasize. ( NCI )] (UMLS (CSP) C0002448) =Neoplastic Process ;
| - 256. Amifostine/Carboplatin/Epirubicin/Paclitaxel
- (UMLS (NCI) C0935734) =Therapeutic or Preventive Procedure
|
- 207. amelogenesis imperfecta
- [An autosomal dominant or X-linked disorder in which there is faulty development of the dental enamel owing to agenesis, hypoplasia, or hypocalcification of the enamel. It is marked by enamel that is very thin and friable and frequently stained in various shades of brown. (Dorland, 27th ed) ( MSH )] (UMLS (CSP) C0002452) =Congenital Abnormality; Disease or Syndrome
| - 257. Amifostine/Carboplatin/Etoposide/Ifosfamide
- (UMLS (NCI) C0796472) CBDCA/IFF/VP-16/WR-2721 =Therapeutic or Preventive Procedure
|
- 208. amelogenin
- [major protein expressed in secretory stage enamel; involved in regulating enamel crystal growth during mineralization; selectively removed from enamel as maturation process. ( CSP )] (UMLS (CSP) C0051560) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Enamel;
Extracellular Matrix Protein | - 258. Amifostine/Carboplatin/Filgrastim/Paclitaxel
- (UMLS (NCI) C0678043) =Therapeutic or Preventive Procedure ;
|
- 209. Amendment
- [A change in a document made by correction, adding, substituting or omitting a certain part. Amendments are the mechanism of changes introduction, further development and improvement of previously submitted or approved clinical study protocols and proposals. ( NCI )] (UMLS (NCI) C0680532) =Intellectual Product
| - 259. Amifostine/Carboplatin/Fluorouracil/Paclitaxel
- (UMLS (NCI) C1134464) =Therapeutic or Preventive Procedure
|
- 210. Amerge
- (UMLS (NCI) C0594660) =Organic Chemical; Pharmacologic Substance ;
| - 260. Amifostine/Carboplatin/Paclitaxel
- (UMLS (NCI) C0677736) =Therapeutic or Preventive Procedure ;
|
- 211. American
- [heading term for all peoples of the Americas (South, Central, and North), or western hemisphere; postcoordinate with a specific country (e.g., UNITED STATES) if necessary. ( CSP )] (UMLS (CSP) C0596070) =Population Group ;
=ethnic group;
=Asian American;
Hispanic American;
African American;
caucasian American;
Central American;
Native American;
South American;
Caribbean | - 261. Amifostine/Carmustine/Cyclophosphamide/Cytarabine/Etoposide
- (UMLS (NCI) C0796503) ARA-C/BCNU/CTX/VP-16/WR-2721;
=Therapeutic or Preventive Procedure ;
|
- 212. American Cocker Spaniel
- [The American Cocker Spaniel has very long hanging ears, a rounded head, and a profuse, feathered, medium-length coat. The body is compact, with a short back. The coat comes in buff, black, other solid colors, black-and-tan, and parti-color (white with black, white with buff or red, white with black and tan points). Height: 14 1/2 -15 1/2 inches (36.8-38 cm.) Weight: 15-30 pounds (7-14 kg.) ( NCI )] (UMLS (NCI) C0324458) =Mammal
| - 262. Amifostine/Ciprofloxacin/Dexamethasone/Pentoxifylline
- (UMLS (NCI) C0677760) =Therapeutic or Preventive Procedure
|
- 213. American College of Radiology finding codes
- [Index for Radiological Diagnosis Revised, 3rd Edition 1986, American College of Radiology, Reston, VA. ( HL7V3.0 )] (UMLS (HL7) C1550182) =Intellectual Product =Code;
CodeSystem | - 263. Amifostine/Ciprofloxacin/Pentoxifylline
- (UMLS (NCI) C0677759) =Therapeutic or Preventive Procedure
|
- 214. American Cutaneous Leishmaniasis
- [A disease characterized by the chronic, progressive spread of lesions from New World cutaneous leishmaniasis caused by species of the L. braziliensis complex to the nasal, pharyngeal, and buccal mucosa some time after the appearance of the initial cutaneous lesion. Nasal obstruction and epistaxis are frequent presenting symptoms. ( MSH )] (UMLS (NCI) C1328252) CUTAN LEISHMANIAS AMER;
Cutaneous leishmaniasis, American;
Leishmaniasis, Mucocutaneous;
MUCOCUTAN LEISHMANIASIS;
Mucocutaneous leishmaniasis, (American) =Disease or Syndrome; ;
=Cutaneous Leishmaniasis;
| - 264. Amifostine/Cisplatin
- (UMLS (NCI) C0280662) =Therapeutic or Preventive Procedure
|
- 215. American Eskimo Dog
- [The American Eskimo is a white Spitz-type dog. It has a wedge-shaped head with muzzle and skull about the same length. It has erect triangular-shaped ears and a heavily plumed tail curled over the back. The profuse coat is always white, or white with biscuit or cream markings. Toy: 9-12 inches (23-30 cm) 6-10 pounds (2.4-4.5 kg) Miniature: over 12 (30 cm) up to 15 inches (38 cm) 10-20 pounds (4.5-9 kg) Standard: over 15 inches (38 cm) up to 19 inches (48 cm) 18-35 pounds (8-16 kg.) ( NCI )] (UMLS (NCI) C0324362) =Mammal
| - 265. Amifostine/Cisplatin/Cyclophosphamide/Etoposide
- (UMLS (NCI) C0678020) =Therapeutic or Preventive Procedure
|
- 216. American Express
- (UMLS (HL7) C1549051) =Organization =Organization, agency, department;
◊ (UMLS (HL7) C1549675) Idea or Concept Identifier type; | - 266. Amifostine/Cisplatin/Cytarabine/Dexamethasone
- (UMLS (NCI) C0677980) =Therapeutic or Preventive Procedure
|
- 217. American Express
- (UMLS (HL7) C1554980) =Quantitative Concept =CreditCard;
| - 267. Amifostine/Cisplatin/Docetaxel
- (UMLS (NCI) C0879412) =Therapeutic or Preventive Procedure
|
- 218. American Foxhound
- [The American Foxhound is a large hound with broad, pendant ears and a short, hard coat. It is taller than most hounds. The short, hard coat may be any color. Height: 21-25 inches (53-64 cm.) Weight: 65-75 pounds (30-34 kg.) ( NCI )] (UMLS (NCI) C0324369) =Mammal
| - 268. Amifostine/Cisplatin/Etoposide
- (UMLS (NCI) C0280936) =Therapeutic or Preventive Procedure
|
- 219. American Indian
- [Denotes a person having origins in one of the indigenous peoples of North America, who lived on the continent prior to the European colonization. The term includes individuals belonging to a large number of tribes, states, and ethnic groups, many of them still enduring as communities. ( NCI )] (UMLS (CSP) C0002460) =Population Group ;
| - 269. Amifostine/Cisplatin/Fluorouracil
- (UMLS (NCI) C0677739) =Therapeutic or Preventive Procedure ;
|
- 220. American Indian or Alaska Native
- [A person having origins in any of the original peoples of North and South America (including Central America), and who maintains tribal affiliation or community attachment. ( NCI )] (UMLS (HL7) C1515945) First Nations;
Native American;
Native Americans;
=Population Group ;
=race;
Race =American Indian;
Alaska Indian | - 270. Amifostine/Cisplatin/Fluorouracil/Paclitaxel
- (UMLS (NCI) C0796643) =Therapeutic or Preventive Procedure
|
- 221. American mole
- [ ] (UMLS (CSP) C0598815) =Mammal ;
| - 271. Amifostine/Cisplatin/Gemcitabine
- (UMLS (NCI) C0677827) =Therapeutic or Preventive Procedure ;
|
- 222. American Public Health Association
- [The oldest and largest organization of public health professionals in the world, representing more than 50,000 members from more than 50 occupations of public health. APHA brings together researchers, health service providers, administrators, teachers, and other health workers, forming multi-disciplinary environment for professional exchange, study, and action. Publishes the American Journal of Public Health. ( NCI )] (UMLS (NCI) C0002465) =Professional Society ;
| - 272. Amifostine/Cisplatin/Interleukin-2
- (UMLS (NCI) C0280272) =Therapeutic or Preventive Procedure
|
- 223. AMERICAN SAMOA
- [A group of islands in the South Pacific Ocean, about half way between Hawaii and New Zealand. (NCI) ( NCI )] (UMLS (NCI) C0242536) =Geographic Area ;
| - 273. Amifostine/Cisplatin/Irinotecan
- (UMLS (NCI) C0879428) =Therapeutic or Preventive Procedure
|
- 224. American trypanosome
- [etiologic agent of Chaga's disease in humans; vertebrate hosts include wild and domestic mammals throughout the Americas, and humans; several species of reduviid bugs are vectors. ( CSP )] (UMLS (CSP) C0041221) =Invertebrate =Trypanosoma;
| - 274. Amifostine/Cisplatin/Monoclonal Antibody R24
- (UMLS (NCI) C0279401) =Therapeutic or Preventive Procedure
|
- 225. American Type Culture Collection
- [A global nonprofit bioscience organization (located at 10801 University Boulevard, Manassas, VA 20110-2209 703-365-2700) that provides biological products, technical services, and educational programs to private industry, government, and academic organizations around the world. Biological products for academic and industrial labs, as well as educational and technical services. For the collection, preservation and distribution of cultures of living microorganisms, viruses, DNA probes, plants, and human and animal ( NCI )] (UMLS (HL7) C0598079) =Intellectual Product ;
=Code;
CodeSystem | - 275. Amifostine/Cisplatin/Paclitaxel
- (UMLS (NCI) C0677679) =Therapeutic or Preventive Procedure
|
- 226. American Water Spaniel
- [The American Water Spaniel is an active, muscular and hardy dog with a broad skull. It has a crisp-textured, tightly curled or wavy outer coat lined with a protective undercoat. Coat colors can include liver or chocolate. Height: 15-18 inches (36-46 cm.) Weight: 25-45 pounds (11-20 kg.) ( NCI )] (UMLS (NCI) C0324455) =Mammal
| - 276. Amifostine/Cyclophosphamide
- (UMLS (NCI) C0281278) =Therapeutic or Preventive Procedure
|
- 227. AmericanIndianAlaskaNativeLanguages
- [American Indian and Alaska Native languages currently being used in the United States. ( HL7V3.0 )] (UMLS (HL7) C1553745) =Language =CodeSystem;
=Haida;
Zu??i;
Kootenai;
Yuchi;
Plains Indian Sign Language;
Caddoan;
KiowaTanoan;
Pidgin;
EskimoAleut;
Hokan;
Iroquoian;
Muskogean;
Salishan;
UtoAztecan;
Nadene;
Penutian;
SiouanCatawba;
Wakashan;
Yukian;
Algic;
Chimakuan;
Keresan;
| - 277. Amifostine/Cyclophosphamide/Doxorubicin/Paclitaxel
- (UMLS (NCI) C0796660) =Therapeutic or Preventive Procedure
|
- 228. AMES mutagen test
- [ ] (UMLS (CSP) C0598910) =Laboratory Procedure; Molecular Biology Research Technique
| - 278. Amifostine/Cyclophosphamide/Mitoxantrone/Thiotepa
- (UMLS (NCI) C0677770) =Therapeutic or Preventive Procedure
|
- 229. Ametycine
- (UMLS (NCI) C0702050) =Organic Chemical; Antibiotic ;
| - 279. Amifostine/Cytarabine/Idarubicin
- (UMLS (NCI) C0678038) =Therapeutic or Preventive Procedure ;
|
- 230. AMF
- [Encoded by human GPI Gene (GPI Family), Glucose-6-Phosphate Isomerase, Neuroleukin, and Autocrine Motility Factor function in different capacities. In glycolysis and gluconeogenesis, homodimeric cytoplasmic GPI catalyzes reversible G6P and F6P isomerization. Produced by lectin-stimulated T-cells, secreted non-mitogenic NLK lymphokine acts early in antibody-secreting cell formation to induce Ig secretion. Also a neurotrophic factor for spinal and sensory neurons, NLK exhibits GPI activity. AMF is a 558-amino acid 55-kD autocrine motility polypeptide. The gene product is partly homologous to a conserved region of HTLV-III-LAV external envelope protein. Gene defects cause nonspherocytic hemolytic anemia and hydrops fetalis. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0085144) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 280. Amifostine/Cytarabine/Mitoxantrone
- (UMLS (NCI) C0678101) =Therapeutic or Preventive Procedure
|
- 231. AMF Receptor
- [Secreted by tumor cells, autocrine motility factor stimulates tumor motility. Its glycoprotein receptor, Autocrine Mobility Factor Receptor, has some homology to p53. In normal fibroblasts, receptor expression appears to be regulated by cell-cell contact. The level of expression is associated with the pathologic stage and grade of tumor penetration. Positive AMFR expression on tumor cells correlates with poor prognosis in bladder cancer. (from OMIM 603243 and NCI) ( NCI )] (UMLS (NCI) C0147219) =Amino Acid, Peptide, or Protein; Receptor
| - 281. Amifostine/Cytarabine/Topotecan
- (UMLS (NCI) C0796610) ARA-C/TOPO/WR-2721 =Therapeutic or Preventive Procedure
|
- 232. Amfetamine
- [powerful central nervous system stimulant and sympathomimetic with multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase; it is also a drug of abuse and a psychotomimetic. ( CSP )] (UMLS (NCI) C0002658) =Organic Chemical; Pharmacologic Substance; Neuroreactive Substance or Biogenic Amine
| - 282. Amifostine/Epoetin Alfa
- (UMLS (NCI) C0796335) EPO/WR-2721;
=Therapeutic or Preventive Procedure |
- 233. AMFR
- [This gene plays a role in tumor cell motility and is associated with several carcinomas. ( NCI )] (UMLS (NCI) C1332083) AMFR Gene;
Autocrine Motility Factor Receptor Gene;
=Gene or Genome | - 283. Amifostine/Etoposide
- (UMLS (NCI) C0796465) VP-16/WR-2721;
=Therapeutic or Preventive Procedure |
- 234. AMG 531
- [A recombinant protein with megakarypoiesis stimulating activity. AMG 531 mimics endogenous thrombopoietin (TPO), directly binding to and activating the platelet thrombopoietin receptor (TPO-R, Mpl, or CD110 antigen), a cytokine receptor belonging to the hematopoietin receptor superfamily. Activation of TPO-R stimulates the proliferation and differentiation of megakaryocytes, resulting in an increase in the production of blood platelets. ( NCI )] (UMLS (NCI) C1505595) Amgen Megakaryopoiesis Protein 2;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance | - 284. Amifostine/Fludarabine
- (UMLS (NCI) C0677844) =Therapeutic or Preventive Procedure ;
|
- 235. AMH Type II Receptor
- [Encoded by human AMHR2 Gene, the 573-amino acid 62.7 kD Anti-Mullerian Hormone Receptor Type II Ser/Thr protein kinase (TGFB Receptor Family) is a type I membrane protein. Type II receptors bind ligand but require a type I receptor for signal transduction. Anti-Mullerian Hormone (AMH/MIS/MIF), produced by Sertoli cells, induces regression of Mullerian ducts, which differentiate into the uterus and fallopian tubes. Type I persistent Mullerian duct syndrome is caused by AMH gene mutation; type II syndrome is due to AMHR mutation. (OMIM, Swiss-Prot, and NCI) ( NCI )] (UMLS (NCI) C0380056) =Amino Acid, Peptide, or Protein; Receptor
| - 285. Amifostine/Irinotecan
- (UMLS (NCI) C0678000) =Therapeutic or Preventive Procedure
|
- 236. AMHR2
- [This gene plays a role in gonadal development. ( NCI )] (UMLS (NCI) C1332084) AMHR2 Gene;
Anti-Mullerian Hormone Receptor, Type II Gene;
=Gene or Genome ;
| - 286. Amifostine/Melphalan
- (UMLS (NCI) C0281015) =Therapeutic or Preventive Procedure
|
- 237. Amicar
- (UMLS (NCI) C0702045) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 287. Amifostine/Mitomycin
- (UMLS (NCI) C0280865) =Therapeutic or Preventive Procedure ;
|
- 238. amidation
- [ ] (UMLS (CSP) C0678615) =Natural Phenomenon or Process
| - 288. Amifostine/Paclitaxel
- (UMLS (NCI) C0338346) =Therapeutic or Preventive Procedure ;
|
- 239. amidation/deamidation
- [addition of or hydrolytic removal of an amide group. ( CSP )] (UMLS (CSP) C0872015) =Phenomenon or Process ;
=chemical reaction;
| - 289. Amifostine/Thiotepa
- (UMLS (NCI) C0280275) =Therapeutic or Preventive Procedure
|
- 240. amide
- [organic compound derived from ammonia by substituting an acyl radical for hydrogen, or from an acid by replacing the OH group by NH2. ( CSP )] (UMLS (CSP) C0002482) =Organic Chemical ;
| - 290. Amifostine/Topotecan
- (UMLS (NCI) C0677737) =Therapeutic or Preventive Procedure ;
|
- 241. amidine
- [monovalent radical or any compound containing -C(NH)-NH2. ( CSP )] (UMLS (CSP) C0002483) =Organic Chemical ;
| - 291. AMIKACIN
- [An antibiotic drug used to treat infection. It belongs to the family of drugs called aminoglycoside antibiotics. ( NCI )] (UMLS (NCI) C0002499) =Carbohydrate; Antibiotic
|
- 242. amidine lyase
- [These enzymes catalyze the elimination of ammonia from amidines with the formation of a double bond. EC 4.3.2. ( MSH )] (UMLS (CSP) C0524943) =Amino Acid, Peptide, or Protein; Enzyme ;
=carbon nitrogen lyase;
| - 292. Amikacin/Ceftazidime
- (UMLS (NCI) C0280693) =Therapeutic or Preventive Procedure
|
- 243. amidinohydrolase
- [ ] (UMLS (CSP) C0002488) =Amino Acid, Peptide, or Protein; Enzyme
| - 293. Amikacin/Ceftriaxone
- (UMLS (NCI) C0280694) =Therapeutic or Preventive Procedure
|
- 244. amidinotransferase
- [Enzymes of a subclass of TRANSFERASES that catalyze the transfer of an amidino group from donor to acceptor. EC 2.1.4. ( MSH )] (UMLS (CSP) C0002484) =Amino Acid, Peptide, or Protein; Enzyme
| - 294. Amikin
- (UMLS (NCI) C0700949) =Carbohydrate; Antibiotic ;
|
- 245. amidophosphoribosyltransferase
- [The protein encoded by this gene is a member of the purine/pyrimidine phosphoribosyltransferase family. This protein is a regulatory allosteric enzyme that catalyzes the first step of de novo purine nucleotide biosynthesis. This gene and PAICS/AIRC, a bifunctional enzyme catalyzing steps six and seven in the purine nucleotide biosynthesis pathway, are located in close proximity on chromosome 4. (from Gene) ( NCI )] (UMLS (CSP) C0002492) =Amino Acid, Peptide, or Protein; Enzyme
| - 295. amiloride
- [pyrazine compound inhibiting sodium reabsorbtion through sodium channels in renal epithelial cells; used in conjunction with diuretics to spare potassium loss. ( CSP )] (UMLS (CSP) C0002502) =Organic Chemical; Pharmacologic Substance ;
|
- 246. Amies transport medium
- (UMLS (HL7) C1550050) =Biomedical or Dental Material ;
=Additive/Preservative;
| - 296. aminacrine
- [highly fluorescent anti-infective dye used clinically as a topical antiseptic and experimentally as a mutagen, due to its interaction with DNA; it is also used as an intracellular pH indicator. ( CSP )] (UMLS (CSP) C0002536) =Organic Chemical; Pharmacologic Substance ;
|
- 247. Amies transport medium
- [Sodium Chloride 3.0g, Potassium Chloride 0.2g, Calcium Chloride 0.1g, Magnesium Chloride 0.1g, Monopotassium Phosphate 0.2g, Disodium Phosphate 1.15g, Sodium Thiogly collate 1.0g, Distilled Water 1 liter ( HL7V3.0 )] (UMLS (HL7) C1561454) =Intellectual Product =MaterialEntityAdditive;
| - 297. amination
- [creation of an amine by the addition of an amino group to an organic compound or reduction of a nitro group. ( CSP )] (UMLS (CSP) C0002505) =Natural Phenomenon or Process
|
- 248. AMIFOSTINE
- [A drug used as a chemoprotective drug to control some of the side effects of chemotherapy and radiation therapy. ( NCI )] (UMLS (NCI) C0015020) =Organophosphorus Compound; Pharmacologic Substance ;
=Organothiophosphorus Compounds;
Protective Agent =AMIFOSTINE 500 MG | - 298. amine
- [group of compounds derived from ammonia by substituting organic radicals for the hydrogens. ( CSP )] (UMLS (CSP) C0002508) =Organic Chemical
|
- 249. Amifostine/Azacitidine
- (UMLS (NCI) C0879480) =Therapeutic or Preventive Procedure ;
| - 299. amine oxidase (copper)
- [A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. EC 1.4.3.6. ( MSH )] (UMLS (CSP) C0019587) =Amino Acid, Peptide, or Protein; Enzyme =amine oxidoreductase;
|
- 250. Amifostine/Bleomycin/Cisplatin/Etoposide
- (UMLS (NCI) C0796553) BLEO/CDDP/VP-16/WR-2721 =Therapeutic or Preventive Procedure
| - 300. amine oxidoreductase
- [ ] (UMLS (CSP) C0002507) =Amino Acid, Peptide, or Protein; Enzyme ;
|
home
